Literature DB >> 21593151

Human T cell leukemia virus type 1 Tax inhibits innate antiviral signaling via NF-kappaB-dependent induction of SOCS1.

Soratree Charoenthongtrakul1, Qinjie Zhou, Noula Shembade, Nicole S Harhaj, Edward W Harhaj.   

Abstract

Human T cell leukemia virus type 1 (HTLV-1) inhibits host antiviral signaling pathways although the underlying mechanisms are unclear. Here we found that the HTLV-1 Tax oncoprotein induced the expression of SOCS1, an inhibitor of interferon signaling. Tax required NF-κB, but not CREB, to induce the expression of SOCS1 in T cells. Furthermore, Tax interacted with SOCS1 in both transfected cells and in HTLV-1-transformed cell lines. Although SOCS1 is normally a short-lived protein, in the presence of Tax, the stability of SOCS1 was greatly increased. Accordingly, Tax enhanced the replication of a heterologous virus, vesicular stomatitis virus (VSV), in a SOCS1-dependent manner. Surprisingly, Tax required SOCS1 to inhibit RIG-I-dependent antiviral signaling, but not the interferon-induced JAK/STAT pathway. Inhibition of SOCS1 by RNA-mediated interference in the HTLV-1-transformed cell line MT-2 resulted in increased IFN-β expression accompanied by reduced HTLV-1 replication and p19(Gag) levels. Taken together, our results reveal that Tax inhibits antiviral signaling, in part, by hijacking an interferon regulatory protein.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21593151      PMCID: PMC3126571          DOI: 10.1128/JVI.00007-11

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  54 in total

Review 1.  Activation of NF-kappaB by HTLV-I and implications for cell transformation.

Authors:  Shao-Cong Sun; Shoji Yamaoka
Journal:  Oncogene       Date:  2005-09-05       Impact factor: 9.867

Review 2.  Mechanisms of type-I- and type-II-interferon-mediated signalling.

Authors:  Leonidas C Platanias
Journal:  Nat Rev Immunol       Date:  2005-05       Impact factor: 53.106

3.  Deregulated expression of CD40 ligand in HTLV-I infection: distinct mechanisms of downregulation in HTLV-I-transformed cell lines and ATL patients.

Authors:  Nicole S Harhaj; Branislava Janic; Juan C Ramos; William J Harrington; Edward W Harhaj
Journal:  Virology       Date:  2007-01-26       Impact factor: 3.616

4.  The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways.

Authors:  Tiejun Zhao; Long Yang; Qiang Sun; Meztli Arguello; Dean W Ballard; John Hiscott; Rongtuan Lin
Journal:  Nat Immunol       Date:  2007-04-29       Impact factor: 25.606

5.  SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine.

Authors:  W S Alexander; R Starr; J E Fenner; C L Scott; E Handman; N S Sprigg; J E Corbin; A L Cornish; R Darwiche; C M Owczarek; T W Kay; N A Nicola; P J Hertzog; D Metcalf; D J Hilton
Journal:  Cell       Date:  1999-09-03       Impact factor: 41.582

6.  Human T cell leukemia virus type I Tax activates CD40 gene expression via the NF-kappa B pathway.

Authors:  Edward W Harhaj; Nicole S Harhaj; Christian Grant; Kate Mostoller; Timothy Alefantis; Shao-Cong Sun; Brian Wigdahl
Journal:  Virology       Date:  2005-03-01       Impact factor: 3.616

7.  Human T-cell leukemia virus type 1 blunts signaling by interferon alpha.

Authors:  Xuan Feng; Lee Ratner
Journal:  Virology       Date:  2008-01-29       Impact factor: 3.616

8.  Essential role for TAX1BP1 in the termination of TNF-alpha-, IL-1- and LPS-mediated NF-kappaB and JNK signaling.

Authors:  Noula Shembade; Nicole S Harhaj; Daniel J Liebl; Edward W Harhaj
Journal:  EMBO J       Date:  2007-08-16       Impact factor: 11.598

9.  Suppressor of cytokine signaling 1 (SOCS-1) and SOCS-3 cause insulin resistance through inhibition of tyrosine phosphorylation of insulin receptor substrate proteins by discrete mechanisms.

Authors:  Kohjiro Ueki; Tatsuya Kondo; C Ronald Kahn
Journal:  Mol Cell Biol       Date:  2004-06       Impact factor: 4.272

10.  Two specific drugs, BMS-345541 and purvalanol A induce apoptosis of HTLV-1 infected cells through inhibition of the NF-kappaB and cell cycle pathways.

Authors:  Emmanuel Agbottah; Wen-I Yeh; Reem Berro; Zachary Klase; Caitlin Pedati; Kyleen Kehn-Hall; Weilin Wu; Fatah Kashanchi
Journal:  AIDS Res Ther       Date:  2008-06-10       Impact factor: 2.250

View more
  36 in total

1.  IKKβ-induced inflammation impacts the kinetics but not the magnitude of the immune response to a viral vector.

Authors:  Emily L Hopewell; Crystina C Bronk; Michael Massengill; Robert W Engelman; Amer A Beg
Journal:  Eur J Immunol       Date:  2012-01-13       Impact factor: 5.532

2.  microRNA-221 restricts human cytomegalovirus replication via promoting type I IFN production by targeting SOCS1/NF-κB pathway.

Authors:  Beizhan Yan; Huimin Ma; Shuting Jiang; Jingli Shi; Ziyi Yang; Weiyan Zhu; Cunquan Kong; Lin Chen; Hui Yan; Cuixia Ma
Journal:  Cell Cycle       Date:  2019-09-24       Impact factor: 4.534

3.  ATM supports gammaherpesvirus replication by attenuating type I interferon pathway.

Authors:  Eric J Darrah; Kyle P Stoltz; Mitchell Ledwith; Vera L Tarakanova
Journal:  Virology       Date:  2017-07-18       Impact factor: 3.616

4.  Modulation of Mitochondrial Antiviral Signaling by Human Herpesvirus 8 Interferon Regulatory Factor 1.

Authors:  Keun Young Hwang; Young Bong Choi
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

5.  Heartland virus antagonizes type I and III interferon antiviral signaling by inhibiting phosphorylation and nuclear translocation of STAT2 and STAT1.

Authors:  Kuan Feng; Fei Deng; Zhihong Hu; Hualin Wang; Yun-Jia Ning
Journal:  J Biol Chem       Date:  2019-04-30       Impact factor: 5.157

Review 6.  The role of ubiquitylation in immune defence and pathogen evasion.

Authors:  Xiaomo Jiang; Zhijian J Chen
Journal:  Nat Rev Immunol       Date:  2011-12-09       Impact factor: 53.106

7.  Aryl Hydrocarbon Receptor Interacting Protein Targets IRF7 to Suppress Antiviral Signaling and the Induction of Type I Interferon.

Authors:  Qinjie Zhou; Alfonso Lavorgna; Melissa Bowman; John Hiscott; Edward W Harhaj
Journal:  J Biol Chem       Date:  2015-04-24       Impact factor: 5.157

8.  Identification of the activator-binding residues in the second cysteine-rich regulatory domain of protein kinase Cθ (PKCθ).

Authors:  Ghazi M Rahman; Sreejesh Shanker; Nancy E Lewin; Noemi Kedei; Colin S Hill; B V Venkataram Prasad; Peter M Blumberg; Joydip Das
Journal:  Biochem J       Date:  2013-04-01       Impact factor: 3.857

9.  HSP90 protects the human T-cell leukemia virus type 1 (HTLV-1) tax oncoprotein from proteasomal degradation to support NF-κB activation and HTLV-1 replication.

Authors:  Linlin Gao; Edward William Harhaj
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

Review 10.  Tumour viruses and innate immunity.

Authors:  Sharon E Hopcraft; Blossom Damania
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2017-10-19       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.